title: The IRIS (Insulin Resistance Intervention after Stroke) trial: A new perspective on pioglitazone.
authors.affiliation: Yale School of Medicine, New Haven, Connecticut, USA. silvio.inzucchi@yale.edu.
authors.forename: Silvio E
authors.initials: SE
authors.lastname: Inzucchi
authors.affiliation: Alpert Medical School, Brown University, Providence, Rhode Island, USA.
authors.forename: Karen L
authors.initials: KL
authors.lastname: Furie
mesh_terms: D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D002546:Ischemic Attack, Transient / Q000188:drug therapy* / Q000517:prevention & control; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000517:prevention & control; D000077205:Pioglitazone; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000188:drug therapy* / Q000517:prevention & control; D045162:Thiazolidinediones / Q000627:therapeutic use*; D015430:Weight Gain / Q000187:drug effects
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone